हिन्दी
English
मराठी
বাংলা
தமிழ்
മലയാളം
ગુજરાતી
తెలుగు
ಕನ್ನಡ
ଓଡ଼ିଶା
Business
Tech
World
Health
NEWS
VIDEOS
PHOTOS
Web Stories
LIVE TV
GO
Latest
India
Ahmedabad
Bengaluru
Chennai
Hyderabad
Kolkata
Mumbai
Pune
Cricket
Success Story
Entertainment
Hollywood
Music
Bollywood
Television
Regional
Movie Review
Lifestyle
Relationship
Travel
Food & Recipes
Fashion
Culture
Spirituality
Business
Economy
Markets
Companies
Real Estate
International Business
Personal Finance
Automobile
Technology
Gadgets
Gaming
Internet & Social Media
Apps
Mobiles
World
Asia
Africa
Americas
Australia-Oceania
Europe
Auto
Mobility
Viral
Diabytes
Fables of Facades
Archived Videos
Newsletter
Fables of Facades
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Advertisement
X
News
COVISHIELD
COVISHIELD News
COVISHIELD
08 May 2024
Covishield Maker AstraZeneca Withdraws Covid-19 Vaccine Globally
According to AstraZeneca, the vaccination has been replaced by revised shots that address novel variations.
DNA Video
30 Apr 2024
DNA: AstraZeneca's Covid vaccine may cause blood clotting
Thrombosis with Thrombocytopenia Syndrome
30 Apr 2024
AstraZeneca's Covishield Vaccine Can Lead To Blood Clots: Know All About TTS
TTS is thrombosis with thrombocytopenia syndrome, which is a clot in blood vessels of the brain or elsewhere, along with a low platelet count TTS has emerged as a rare but significant concern associated with the AstraZeneca Covid-19 vaccine A doctor, however, emphasised that these findings don't change the fact that the vaccines were essential to fight COVID-19
COVID-19
03 Sep 2022
Man demands Rs 1,000 crore from Covid-19 vaccine makers for daughter's death
A man has filed a petition seeking a response from the makers of Covishield claiming that the vaccine caused his daughter's death He has demanded a compensation of Rs 1,000 crore from the Indian-vaccine maker Serum Institute of India (SII)
corbevax
10 Aug 2022
Corbevax cleared as Covid booster dose for Covaxin, Covishield recipients
Govt clears Corbevax as Covid-19 booster dose for adults vaccinated with Covaxin, Covishield Health Ministry's approval is based on the recommendations made by the NTG Corbevax is currently being used to inoculate children in the age group of 12 to 14 years under the COVID-19 immunisation programme.
corbevax
04 Jun 2022
CORBEVAX becomes first vaccine in India to get approval for COVID booster dose
CORBEVAX has become the first vaccine in India to get DCGI approval for COVID-19 booster dose. People who are 18 years & above & have already taken two doses of either COVISHIELD or COVAXIN can now receive a dose of CORBEVAX. The vaccine can be taken after 6 months of two doses of Covaxin or Covishield vaccines for restricted use in emergency situation.
Monkeypox
02 Jun 2022
Monkeypox cases due to the side effect of Covid-19 vaccine? Answer here
Monkeypox outbreak: Social media posts claiming the chimpanzee adenovirus vector used in AstraZeneca's Covid vaccine, causes Monkeypox have surfaces, PTI reported.
covid vaccine
07 May 2022
Sputnik booster dose approved in India, over 6.5 lakh people eligible: Report
Sputnik booster dose has been approved in India. Over 6.5 lakh people who have received Sputnik vaccine will be eligible to take the booster dose. India had earlier approved a third dose of COVID vaccines – Covaxin and Covishield – for adults.
covid vaccine
30 Apr 2022
Several vials of Covid vaccine found in garbage dump in UP’s Kannauj
Several vials of Covid vaccine found in a garbage dump in UP. A probe has been ordered in this regard. A vial of Covishield is opened only when 10 patients are available to take the dose.
Vaccine
08 Apr 2022
No more free of cost, Serum finalises the price of Covishield Booster dose
Government have decided to allow Coronavirus booster shots to all adults from Sunday The third jab will not be free for most adults Mr Poonawala said that Serum Institute will offer large discounts to hospitals and distributors
Fourth Wave
04 Apr 2022
Fourth wave of Covid-19 to hit India? Here's what SII CEO Adar Poonawalla says
Speaking to reporters on the sidelines of the ‘Alternate Fuel Conclave’, the SII CEO said the reason behind the low number of Covid-19 cases at the moment is that the country chose the right vaccine.
Covid-19 fourth wave
21 Mar 2022
Amid fourth wave scare, expert body suggests reducing gap b/w Covishield doses
India's apex body on immunisation NTAGI has recommended administering the second dose of Covishield between eight and 16 weeks after the first dose.
COVISHIELD
20 Mar 2022
Reduce Covishield dose gap to 8-16 weeks, recommends panel
The National Technical Advisory Group on Immunisation has recommended reducing the Covishield dose gap. Presently, the second dose of Covishield is being administered 12-16 weeks after the first dose. India continues on a downward trend of new Covid cases.
COVID-19 vaccine
03 Feb 2022
Misleading: Centre on reports claiming 50L unused Covishield jabs may go waste
Health ministry has denied Covishield doses going to waste reports. The health ministry said states were advised that no vaccine dose gets expired.
COVID-19
26 Jan 2022
Covishield, Covaxin likely to be capped at Rs 275 after regular market nod
Covaxin and Covishield were granted Emergency Use Authorisation (EUA) on January 3 last year Serum Institue of India had submitted application to DCGI seeking regular market approval for Covishiled
Vaccine
20 Jan 2022
Govt panel recommends regular market approval for Covishield, Covaxin
An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to Covid vaccines Covishield and Covaxin, which are currently only authorised for emergency use in the country, subject to certain conditions, official sources said.
COVID-19 vaccine
04 Jan 2022
Is mixing and matching Covishield, Covaxin safe? Study provides BIG update
A total of 330 volunteers, who were not vaccinated and had no history of the COVID-19 infection, were selected and screened for SARS-CoV-2 antibodies for the study.
COVISHIELD
23 Dec 2021
Lancet study about Covishield 3 months efficacy misquoted, say experts
Scientific data available says that vaccines provide antibodies, said Dr JA Jayala It will be preventing you and helping you to come out of the severe infection, said Jayala
COVISHIELD
10 Dec 2021
Covishield booster: Subject Expert panel to meet today to discuss approval
The SII has recently filed an application with the DCGI regarding approval for a booster dose of Covishield It cited that there is adequate stock of the Covid vaccine in the country A demand for a booster shot is there due to the emergence of new coronavirus variants
Serum Institute of India
01 Dec 2021
Third jab soon? Serum Institute asks DCGI to allow Covishield as booster dose
SII cited adequate stock of the vaccine in the country and a demand for a booster.
1124807
1
9
Loading...
Trending news
DNA Video
DNA: Anmol Bishnoi Seeks Asylum in the U.S.
DNA Video
DNA: Adani Case - Corruption Allegations Rock Indian Markets
DNA Video
DNA: Were Muslims Stopped from Voting in UP By-Elections?
DNA Video
DNA: Who Did Maharashtra’s Muslims Vote For?
DNA Video
DNA: Russia-Ukraine Conflict Escalates Amid Missile Attacks
DNA Video
DNA: The Beer-Loving Buffalo Stuck in Bihar!
DNA Video
DNA: Akhilesh and the Burqa Controversy in UP Elections
DNA Video
DNA: Is the Opposition to ‘Bantenge To Katenge’ Part of a Larger Plan?
DNA Video
DNA: RSS Master Plan: From Maharashtra to UP
DNA Video
DNA: Bengal’s Waqf Property Controversy
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
×
Cookies Settings
Reject
Accept Cookies
NEWS ON ONE CLICK